Cyclosporine
Oral
Intravenous
Ophthalmic
Class
Immunophilin ligands
Subclass
Calcineurin inhibitors
Generic name
Cyclosporine, cyclosporin, ciclosporin
Brand names
Neoral®, Sandimmune®, Verkazia®, Vevye®
Common formulations
Capsule, Oral solution
Dosage and administration
Adults patients
Atopic dermatitis • Moderate-to-severe • Off-label
Myasthenia gravis • Off-label
Plaque psoriasis • Off-label
Other off-label uses
Indications for use
Labeled indications
Adults
Off-label indications
Adults
Safety risks
Boxed warnings
Malignancy, lymphoma
Reactivation of viral infections, polyoma virus infection
Contraindications
Hypersensitivity to cyclosporine or polyoxyethylated castor oil or any of its components
Warnings and precautions
Cholestasis
Hepatotoxicity, nephrotoxicity
Hyperkalemia
Neurotoxicity
Thrombotic microangiopathy
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Renal replacement therapy
Continuous renal replacement
Intermittent hemodialysis
Peritoneal dialysis
Hepatic impairment
Child-Pugh A (mild)
Child-Pugh B (moderate)
Child-Pugh C (severe)
Substantial chronic alcohol consumption
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: C
Breastfeeding
Acceptable for use during breastfeeding.
Low excretion in breastmilk (5-25%).
Very low levels in breastfed infants (< 5%).
Unlikely to cause adverse effects in breastfed infants.
Adverse reactions
Very common > 10%
Common 1-10%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource